Prevalence of Chronic Kidney Disease in Tunisian Diabetics

NCT05577650 | Completed

• 1 other identifier: DAC-013-TUNCKDD
• Study Type: observational
• Target: 10,145
• Locations: 1 country
• Sites: 1

Brief Summary

In Tunisia, diabetes is a serious public health problem, its prevalence reaches 22.9% of people aged 18 and over and is likely to affect a quarter of the population by 2045. Diabetic kidney disease is the most common and severe complication of diabetes. It is both a major cause of end-stage renal disease and a risk factor for mortality and cardiovascular morbidity, thus becoming an additional public health concern. Early diagnosis of diabetic kidney disease makes it possible to manage patients more effectively and in a multidisciplinary way, to delay its progression to chronic renal failure.

Conditions

Chronic Kidney Diseases; Diabetes Mellitus; Diabetes Type 2

Keywords

Chronic Kidney Disease; Diabetes; Survey

Outcome Measures

Primary Outcomes (1)

• Prevalence of chronic kidney disease

  Frequency of diabetic subjects with chronic kidney disease

  At inclusion

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All diabetic subjects with at least 3 months of follow-up, before the inclusion date.

You may qualify if:

• Age \> 18 years old
• Diabetes Type 1 or Type 2
• Follow-up at the consultation for at least more than 3 months
• Informed consent of the patient

You may not qualify if:

• Kidney transplant
• Chronic dialysis

Sponsors & Collaborators

• Dacima Consulting: lead
• Tunisian Society for Nephrology, Dialysis and Renal Transplantation: collaborator

Study Sites (1)

Tunisian Society for Nephrology, Dialysis and Renal Transplantation

Tunis, 1000, Tunisia

Location

Related Links

• FB page of STNDTR

MeSH Terms

Conditions

Renal Insufficiency, Chronic; Diabetes Mellitus; Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Labidi Jannet, MD

  Military Hospital of Tunis (Tunis, Tunisia)

  STUDY CHAIR

• Amel Harzallah, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Awatef Azzabi, MD

  University Hospital of Sahloul (Sousse, Tunisia)

  PRINCIPAL INVESTIGATOR

• Badreddine Ben Kaab, MD

  La Marsa Internal Security Forces Hospital (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Ikram Mami, MD

  University Hospital of La Rabta (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Lamia Rais, MD

  University Hospital of La Rabta (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Maissa Hadji Brahim, MD

  University Hospital of Taher Sfar (Mahdia, Tunisia)

  PRINCIPAL INVESTIGATOR

• Mouna Hammouda, MD

  University Hospital of Fattouma Bourguiba (Monastir, Tunisia)

  PRINCIPAL INVESTIGATOR

• Sahar Agrebi, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Seifeddine Azaiez, MD

  Private Clinic (Ben Arous, Tunisia)

  PRINCIPAL INVESTIGATOR

• Soumaya Chargui, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 10, 2022
• First Posted: October 13, 2022
• Study Start: January 9, 2023
• Primary Completion: February 12, 2023
• Study Completion: February 12, 2023
• Last Updated: May 10, 2023

Record last verified: 2023-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)